We are in the pre-registration phase of what has been called the most intrusive legislation ever confronted by the chemical industry: REACH (Registration, Evaluation and Authorization of Chemicals). It might appear monumentally frustrating and discouraging to small and medium-sized non-European manufacturers. However, compliance with REACH is quite manageable, and close attention to market activity can be of great strategic value. Pre-registration is not difficult, and it allows sales to continue while an accompanying market watch can influence or drive future REACH decisions. This presentation is not a typical list of “do’s and don’ts” regarding the legislation. Instead, it will focus on the business of REACH and will explore the business process that determines the REACH value equation.